You are here

A piece of news

BcnHighGrowth is born from the fusion of Highgrowth and Barcelona Emprèn

AddToAny buttons: 

Two of the pioneering risk asset biotechnology business agents in Catalonia, Highgrowth and Barcelona Emprèn, have merged to create the new business agent BcnHighgrowth. This new firm will have shareholding in 23 companies and will manage over 50 million Euros.

The fusion of these two organisations will allow the new business agent to win size and investment capacity, reduce structural costs and orientate the firm in accordance to the international models that believe the private professional management, even, in public asset funds.

BcnHighGrowth will manage three funds: FonsInnocat, with a capital of 20 million; Highgrowth Innovation, with 14 million; and Barcelona Emprèn (with shareholding of the Barcelona City Council and Catalan Institute of Finances) which after an imminent enlargement will reach the 16 million Euros. Among the funds’ investors we find private insurance companies of big corporations such as Telefónica, BBVA, La Caixa and Caixa Catalunya.

Highgrowth and BCN Emprèn are risk capital pioneers in Catalonia. They participate in top companies of the biotechnological sector in Catalonia. Among its main shareholding we highlight Archivel Farma, which develops therapeutic vaccines against tuberculosis, and Era Biotech, specialized in vegetal origin proteins manufacturing.

Related content: